Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 19.

Moch, H; Blank, P R; Dietel, M; Elmberger, G; Kerr, K M; Palacios, J; Penault-Llorca, F; Rossi, G; Szucs, T D (2012). Personalized cancer medicine and the future of pathology. Virchows Archiv, 460(1):3-8.

Blank, P R; Moch, H; Szucs, T D; Schwenkglenks, M (2011). KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspective. Clinical Cancer Research, 17(19):6338-6346.

Szucs, T D; Blank, P R; Schwenkglenks, M; Aapro, M (2011). Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81(1):45-49.

Blank, P R; Dedes, K J; Szucs, T D (2010). Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review. PharmacoEconomics, 28(8):629-647.

Blank, P R; Blank, A A; Szucs, T D (2010). Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective. BMC Dermatology, 10:4.

Blank, P R; Schwenkglenks, M; Moch, H; Szucs, T D (2010). Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies. Breast Cancer Research and Treatment, 124(2):497-507.

Michel, J P; Gusmano, M; Blank, P R; Philp, I (2010). Vaccination and healthy ageing: How to make life-course vaccination a successful public health strategy. European Geriatric Medicine, 1(3):155-165.

Blank, P R; Schwenkglenks, M; Szucs, T D (2009). Disparities in Influenza Vaccination Coverage Rates by Target Group in Five European Countries: Trends Over Seven Consecutive Seasons. Infection, 37(5):390-400.

Blank, P R; Szucs, T D (2009). Increasing influenza vaccination coverage in recommended population groups in Europe. Expert Review of Vaccines, 8(4):425-433.

Endrich, M M; Blank, P R; Szucs, T D (2009). Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine, 27(30):4018-4024.

Blank, P R; Schwenkglenks, M; Szucs, T D (2009). Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. Journal of Infection, 58(6):441-453.

Blank, P R; Freiburghaus, A U; Ruf, B R; Schwenkglenks, M M; Szucs, T D (2008). Trends in Influenza Vaccination Coverage Rates in Germany over Six Seasons from 2001/02 to 2006/07. Medizinische Klinik, 103(11):761-768.

Nicoll, A; Ciancio, B C; Tsolova, S; Blank, P R; Yilmaz, C (2008). The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Eurosurveillance, 13(43):1-8.

Blank, P R; Freiburghaus, A U; Schwenkglenks, M; Szucs, T D; Kunze, U (2008). Influenza vaccination coverage rates in Austria in 2006/07 - a representative cross-sectional telephone survey. Wiener Medizinische Wochenschrift, 158(19-20):583-588.

Blank, P R; Schwenkglenks, M; Szucs, T D (2008). Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health, 8:272.

Blank, P R; Freiburghaus, A U; Schwenkglenks, M; Szucs, T D (2008). Trends in influenza vaccination coverage rates in the United Kingdom over six seasons from 2001-2 to 2006-7. Euro Surveillance, 13(43):1-7.

Holm, M V; Blank, P R; Szucs, T D (2007). Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006. Vaccine, 25(46):7931-7938.

Holm, M V; Blank, P R; Szucs, T D (2007). Influenza vaccination coverage rates in Europe – covering five consecutive seasons (2001–2006) in five countries. Influenza and Other Respiratory Viruses, 1(5-6):215-221.

Holm, M V; Blank, P R; Szucs, T D (2007). Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infectious Diseases, 7:144.

This list was generated on Tue Oct 17 14:34:10 2017 CEST.